Medical Xpress January 13, 2022
Riley Griffin, Angelica Peebles and Emma Court

JPMorgan Chase & Co.’s annual healthcare conference in San Francisco, which will wrap up on Thursday, has long been considered the industry’s flagship event. Executives flock to outline priorities for the year ahead, or set plans in motion behind closed doors. It’s a stage on which to announce deals or a setting for clinching them.

However, after the caused a surge in coronavirus cases, the event, now in its 40th year, was forced to go virtual for the second January in a row. While that meant less mingling over cocktails and more squinting at laptops, there’s still plenty to be divined from the health sector’s favorite crystal ball.

Here are five takeaways:

Rna is having a moment

Those...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Conferences / Podcast, Market Research, Pharma / Biotech, Trends
mRNA Vaccine Shows Promise In Pancreatic Cancer Trial
Hims & Hers vs. Novo Nordisk: Are Compounded GLP-1s Safe?
On Heels of FDA Nod, BridgeBio’s Rival to Blockbuster Pfizer Drug Wins European Approval
The First Diagnostic Immunome
Cash-Strapped Gene Therapy Firm Bluebird Bio Agrees to Acquisition by Private Equity

Share This Article